A higher rate of de novo fatty acid synthesis was found in PAH-HPASMC, and increased expression of FASN was observed in the lungs of MCT-treated rats (Singh et al., 2016) and human PAH pulmonary arterial vascular smooth muscle cells (PAVSMC) (Jiang et al., 2022). Here, FASN is linked to pulmonary arterial hypertension.